Skip to main content
. 2020 Sep 18;21(18):6862. doi: 10.3390/ijms21186862

Figure 5.

Figure 5

Bone marrow smears after 3 cycles of decitabine of clinical case 1. The reduction of marrow blasts with persistence of trilineage dysplasia and a residual thrombocytopenia are consistent with an optimal marrow response according to proposed international criteria [36].